Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,680 | 20,210 | 25,700 | 26,660 | 32,340 |
| Marketable Securities | 29,660 | 27,580 | 24,500 | 27,270 | 23,350 |
| Other current assets | 640 | 620 | 390 | 450 | 260 |
| TOTAL | $45,980 | $48,410 | $50,590 | $54,380 | $55,950 |
| Non-Current Assets | |||||
| PPE Net | 1,240 | 1,210 | 1,190 | 1,110 | 1,050 |
| Investments And Advances | 490 | 710 | 1,460 | 1,450 | 3,150 |
| Other Non-Current Assets | 910 | 940 | 960 | 980 | 1,010 |
| TOTAL | $2,640 | $2,860 | $3,610 | $3,540 | $5,210 |
| Total Assets | $47,640 | $50,300 | $53,260 | $57,010 | $60,260 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 680 | 640 | 410 | 390 | 690 |
| Accrued Expenses | 3,530 | 3,370 | 3,620 | 2,950 | 3,040 |
| TOTAL | $4,220 | $4,020 | $4,040 | $3,340 | $3,730 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,220 | $4,020 | $4,040 | $3,340 | $3,730 |
| Shareholders' Equity | |||||
| Common Shares | 280 | 280 | 280 | 280 | 280 |
| Retained earnings | -117,410 | -114,010 | -110,280 | -105,290 | -101,950 |
| Other shareholders' equity | -10 | -230 | -300 | -290 | -2,680 |
| TOTAL | $43,420 | $46,280 | $49,210 | $53,660 | $56,530 |
| Total Liabilities And Equity | $47,640 | $50,300 | $53,250 | $57,000 | $60,260 |